Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannAssist International Corp. (CNSC) Focused on Leveraging Position in Growing Cannabis Industry through Strategic Marketing Plan

Vast opportunities exist in growing cannabis space
CannAssist is committed to establishing aggressive marketing presence in promising market
CannAssist brings impressive advancements, achievements to the table, including its propriety CiBiDinol technology

Carefully developing and executing a strategic go-to-market plan has never been more important for companies operating in the cannabis industry, according to a recent “Rolling Stone” article (https://cnw.fm/uMoi5). The article urges cannabis companies to consider the industry from both a competitive perspective as well as an opportunity angle, which is exactly what CannAssist International (OTCQB: CNSC) has done as it looks toward 2021 and a projected $5.8 million share of the market.

“The 2020 election was another exciting turning point: Four new states joined the 12 existing markets with legal recreational cannabis, bringing adult use to 15 regions in just eight short years,” the “Rolling Stone” article reported. “Nearly one in three Americans now live in a state where those aged 21 and older can purchase and possess cannabis freely. This will likely expand significantly with the addition of more East Coast markets poised to legalize in the near future through legislation in New York, Pennsylvania and Connecticut.

“It gets even better,” the article continued. “With a new federal administration comes the likelihood of a mandate to decriminalize cannabis and a path to legalization through bills in Congress such as the passing of the MORE Act by the House of Representatives, with its lead sponsor Vice President Kamala Harris. Consumer sentiment favoring legalization is expanding. According to findings from Pew Research from 2019, two-thirds of Americans approve of adult-use in what has become one of those rare bipartisan issues with differences of opinion occurring predominantly along generational lines.”

CannAssist recognizes the wave of opportunity flooding the cannabis market and is committed to establishing an aggressive marketing presence using tactics across the entire marketing funnel plan as part of its go-to-market strategy (https://cnw.fm/cDw0H). In part, the company will focus on retail partnership, brand collaborations and influencer programming. In addition, CannAssist is eyeing large-scale video and content capture and will also evaluate avenues for digital advertising, email marketing, and both paid and organic social media engagement.

These efforts are designed to support the company’s efforts to reach its goals in five key product areas: Xceptol Capsules M($1 million), Xceptol Drops ($532,000), Xceptol Pain Cream ($1.27 million), Xceptol Pet product ($130,000), and raw material from its Xceptor Labs ($1.48 million). CannAssist owns Xceptor Labs, which produces and markets the Xceptol brand product line and also produces superior quality raw materials for third-party company use.

A biotechnological pharmaceutical and wellness company, CannAssist brings impressive advancements and achievements to the table—none more notable than its development of CiBiDinol, which simply put is cannabidiol made water compatible (https://cnw.fm/JGyB1). CiBiDinol addresses critical issues regarding CBD molecules, including delivery, bioavailability and short shelf life, by offering predictable potency, reduced dosage requirements and a wider variety of product forms.

Established in May 2017, CannAssist is headquartered in San Diego County, California, and markets its consumer line of cannabidiol (“CBD”) products under the Xceptol brand. CNSC is currently targeting North America, Central America, South America, South Africa, the EU, the UK and the Philippines as viable product markets. The company has established strategic partnerships in sourcing, manufacturing, processing, laboratory, distribution, public relations and legal representation.

For more information, visit the company’s website at www.CannAssistInternational.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSC are available in the company’s newsroom at https://cnw.fm/CNSC

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Enters Share Purchase Agreement with Lords of Grasstown

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”) today announced its entry into a share purchase agreement with the shareholders of Lords of Grasstown Holdings Ltd., a company existing under the laws of British Columbia (“Grasstown”) pursuant to which the company will acquire all the issued and outstanding shares of Grasstown (the “transaction ”). According to the update, Grasstown is a well-established cannabis motorcycle lifestyle brand with a tremendous following and acumen that spawned from the vision of Tyler Hazelwood, founder and director of Lords of Gastown. “PacRoots is thrilled to partner with such an incredible brand and story driven by artists with a passionate vision that resonates throughout a massive community,” said PacRoots’ president and CEO Patrick Elliott. “The creators, designers and marketers behind Lords of Grasstown have a truly unique and talented offering that will be invaluable to the PacRoots organization. The Grasstown culture compliments PacRoots’ foundation of variety and quality built on the west coast. This platform brings a tremendous following that embraces these attributes, which are well positioned to excel in BC and California’s west coast marketplaces.”

To view the full press release, visit https://cnw.fm/KImaZ

About Pac Roots Cannabis Corp.

Pac Roots is the future of genetics. By focusing on elite cannabis genetic development, the company maximizes the quality of its products, by keeping yields and profit margins high. Pac Roots subsidizes costs with several strategic partners; Phenome One, one of the largest live genetic libraries in Canada composed of over 350+ live cultivars as well as its JV partnership with Rock Creek Farms and Speakeasy Cannabis Club, leveraging existing infrastructure, equipment and access to land on a 100-acre hemp project. This combination has the company positioned to be cash-flow positive within their first year of trading. For more information about the company, visit www.PacRoots.ca.

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots are available in the company’s newsroom at http://cnw.fm/PACR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) to Supply HempFusion CBD for Potentially Groundbreaking Research at Mount Sinai Medical Hospital

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that Mount Sinai Medical Hospital, New York City, has selected HempFusion CBD as the exclusive brand and the sole supplier in a six-month clinical trial. Dr. David Harnick, a board-certified cardiologist and electrophysiologist and assistant professor in medicine and cardiology at Mount Sinai, is conducting the trial comprised of two studies that is one of the first of its kind in the area of CBD’s effect on targeted cardiology markers. “Studying the potential effects that CBD may have on cardiology markers may potentially unlock some of the scientific mysteries that exist today,” said Dr. Harnick. “We know that there is evidence that CBD may have beneficial effects on the body, but the exact scope of those effects remains to be determined. There have been no published randomized prospective controlled trials evaluating the effects of CBD on these cardiac markers, so this research may prove to be groundbreaking.”

To view the full press release, visit https://cnw.fm/wrogo

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA drug listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the U.S. Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in-store or by visiting HempFusion online at www.Hempfusion.com or www.Probulin.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Senate Leaders Have First Meeting to Discuss Cannabis Legalization Plan

The past few years have seen several states legalize recreational or medical cannabis. By 2020, more than 30 states allowed cannabis in various forms, and there was hope that eventually the wave of cannabis reform would reach the federal level. Toward the end of the year, the U.S. House of Representatives passed a cannabis decriminalization bill that would definitely have stalled in the then Republican-controlled Senate. However, the Democrats clinched both the House and Senate majority, renewing the hope that one day, cannabis would be legal at the federal level.

In late January, Senate Majority leader Chuck Schumer hosted a meeting with marijuana stakeholders, beginning the long journey toward finally legalizing cannabis at the federal level. The Democrat was joined by Senate Finance Committee Chair Ron Wyden and Senator Cory Booker, as well as representatives from advocacy groups and the fledgling cannabis industry. The guests included staffers from Drug Policy Alliance (“DPA”) and Students for Sensible Drug Policy as well as other organizations with ties to the Marijuana Justice Coalition, according to sources who attended the hour-long meeting.

In a joint statement released before the meeting took place, the trio of senators, who are at the forefront of cannabis reform, said they would release draft legislation in the coming weeks to help paint a picture of what federal legalization would look like. They stated that the war on drugs and marijuana policing, in particular, had failed, and they called for a change in federal policy that would focus on repairing the harms of the decades’ long war on drugs.

Topics that were discussed during the meeting include the regulatory structure for cannabis, tax policy and social equity. Attendees say one issue the senators were especially committed to was a Senate bill that at minimum would deschedule cannabis and replace current anti-cannabis legislation with a justice and equity-focused policy. Although the senators didn’t go into much detail about what the cannabis bill would eventually look like, they signaled that they would incorporate the feedback they received during the meeting and from other sources.

Amber Littlejohn, executive director at the Minority Cannabis Association (“MCBA”), says the meeting between the senators, advocates and industry stakeholders was historic, especially since Schumer, Booker and Wyden want to make equity and justice the foundation of the legislation. Queen Adesuyi, policy manager of national affairs for the Drug Policy Alliance, also praised the senators’ efforts, saying that seeing “such a dynamic trifecta of leadership” working on delivering justice to communities that were most affected by the war on drugs is exciting.

Booker is expected to be the legislation’s lead sponsor once proposed legislation is filed, after which the bill would likely be referred to Wyden’s committee.

Next door in Canada, cannabis was legalized years back, opening up plenty opportunities for companies to seize. An example of that is the way Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) opted to leverage high-end cannabis genetics as well as the best-in-class cultivars in order to produce cannabis products of premium quality.

NOTE TO INVESTORS: The latest news and updates relating to Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) are available in the company’s newsroom at http://cnw.fm/PACR

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Legislators in South Dakota Remain Hopeful about Cannabis Legalization

A circuit judge’s decision to hinder a voter-approved initiative that legalized adult-use cannabis from progressing in South Dakota isn’t discouraging legislators from advancing with a series of marijuana related measures. While many doubt that cannabis prohibition will end soon in South Dakota after Judge Christina Klinger overturned Constitutional Amendment A, some lawmakers are working on legalizing cannabis through the statutes of the state.

Before heading into a strategy meeting with other legislators and lobbyists, Senator Brock Greenfield told reporters that legalizing was still a real possibility and that planning ahead for any situation was the best option.

Defendants legally challenging the judge’s decision to strike down Constitutional Amendment A are expected to appeal the decision to the state’s Supreme Court. Greenfield asserted that if the judge’s decision wasn’t revoked after the appeal, he would expect that South Dakotans for Better Marijuana Laws, which was responsible for placing the initiative on the voters’ ballot, would try to legalize cannabis again.

However, several legislators argue that trying to legalize cannabis again through the legislative way may give rise to better results. Senator Arthur Rusch stated that among the many flaws of the initiative was that it gave all its rule-making powers to the state’s Department of Revenue, which many lawmakers were not on board with.

Rusch said that if the Supreme Court decided to uphold the circuit judge’s ruling, then the state’s best option for legalizing cannabis would be to assemble all stakeholders and try to negotiate and draft a policy that would encompass the voters will but refrain from conflicting with other regulations in the state’s constitution. Rausch, who is a former attorney and judge, stated that Amendment A contained some flaws, noting that advocates would be better off if they collaborated with advocacy groups that were working on cannabis, partnering together to draft a measure that was satisfactory to everyone.

The deadline for filing new measures for the legislative session in the state has already passed. However, Greenfield has come up with a vehicle bill that can be used to carry any cannabis-related bills that are yet to be recorded by the Legislative Research Council by the now expired deadline. The vehicle bill could, for instance, allow Constitutional Amendment A’s language to be added into Greenfield’s bill collectively before being proposed formally to his colleagues for consideration.

The good news is that Measure 26, which legalized medical cannabis in the state, has not been affected by the ruling and is set to go into effect on July 1, 2021.

Meanwhile, lots of benefits are accruing from the legalization of cannabis in other states around the country. For example, Green Hygienics Holdings Inc. (OTCQB: GRYN) has taken major strides towards distinguishing itself as a leader with regard to its capabilities within the highly competitive supply chain of cannabinoids.

NOTE TO INVESTORS: The latest news and updates relating to Green Hygienics Holdings Inc. (OTCQB: GRYN) are available in the company’s newsroom at http://cnw.fm/GRYN

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Closing Soon: Fast Flower Farms SPV Investment Opportunity

Fast Flower Farms & The Artisanal Cannabis Connoisseur

While cannabis companies have recently raised hundreds of millions in an attempt to bring ‘craft cannabis’ to scale, many consumers prefer cannabis that is cultivated by craft growers rather than large corporations. Enter artisanal cannabis products.

Artisanal Products

Artisanal products create value via limited production, emphasis on quality, and creation by industry connoisseurs. Artisan flower is grown in small batches and is manicured by hand, unlike commercial flower which is done with machines. Artisanal production combined with superior genetics that have limited market availability increases consumer demand and builds brand loyalty.

Solventless ‘Live’ Extracts

Solventless extraction is a process of extraction that uses cold water and agitation to separate the medicinal part of the plant, trichomes, from the leafy green material. This methodology keeps cannabinoids and terpenes intact and has emerged as the preferred extraction trend for high-end consumers, over the use harsh solvents. Another step up the quality ladder is using the solventless extraction process is to create a ‘live’ extract. This involves freezing freshly harvested flowers, eliminating terpene, cannabinoid and trichome degradation caused by the oxidation process of drying. The extracts from this process are considered the ‘holy grail’ of extracts.

Michigan

Michigan has quickly emerged as a powerhouse for cannabis companies, ranking #2 in the nation for medical cannabis patients – behind only California. Its average basket size is a whopping 30% greater than California’s at $84.58 vs. $64.13, a number even more striking when one looks at average annual household income – $56,697 in Michigan, compared to $101,493 in California.

Fast Flower Farms

Fast Flower Farms, a company based in Bay City, MI, boasts years of cannabis experience and a deep genetic library. Specializing in artisanal flower and ‘live’ solventless extracts, Fast Flower Farms is poised to appeal to the high margin artisanal cannabis connoisseur.

Investors can now participate in Fast Flower Farm’s journey, starting at $5,000, via MAZAKALI’s SPV in the company. This SPV has already been funded and will close in one week, on February 23^rd, 2021.

Please access the opportunity HERE and reach out to banking@mazakali.com with questions.

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Third-Party Content

The CNW website may contain Third-Party Content articles and other content submitted by third parties, including articles submitted through the CNW Premium Partnership Program. All opinions, statements and representations expressed by such third parties are theirs alone and do not express or represent the views and opinions of CNW or its affiliates and owners. Content created by third parties is the sole responsibility of such third parties, and CNW does not endorse, guarantee or make representations concerning the accuracy and completeness of any third-party content. You acknowledge that by CNW providing you with this internet portal that makes accessible to you the ability to view third party content through the CNW site, CNW does not undertake any obligation to you as a reader of such content or assume any liability relating to such third-party content. CNW expressly disclaims liability relating to such third-party content. CNW and its members, affiliates, successors, assigns, officers, directors, and partners assume no responsibility or liability that may arise from the third-party content, including, but not limited to, responsibility or liability for claims for defamation, libel, slander, infringement, invasion of privacy and publicity rights, fraud, or misrepresentation, or an private right of action under the federal securities laws of the United States or common law. Notwithstanding the foregoing, CNW reserves the right to remove third-party content at any time in its sole discretion. By viewing this third-party content, you acknowledge that you have viewed, read fully, accepted and agreed to all terms of the Disclaimer at https://www.cannabisnewswire.com/disclaimer.

420 with CNW — South Dakota Circuit Judge Nullifies Cannabis Legalization Measure

A South Dakota circuit judge has rejected an amendment that was approved by voters in the state during the November polls, ruling it as unconstitutional. The judge, who had been appointed by South Dakota Gov. Kristi L. Noem, stated that the change, which would end cannabis prohibition in the state, should not proceed.

Judge Christina Klinger supported her ruling by stating that Constitutional Amendment A violated the state’s constitution as it conflicted with the constitution’s language, in addition to defying single subject rule.

Pennington County Sheriff Kein Thom and the South Dakota Highway Patrol Superintendent Rick Miller, as well as attorneys for the case’s plaintiffs, argued in January that Constitutional Amendment A ought to be viewed as a revision instead of an amendment because it did not modify an existing clause in the state’s constitution but added a completely new section to the constitution of the state.

Klinger, however, stated that a failure to present Constitutional Amendment A through the proper process as cited in the constitution not only had no effect but also nullified the amendment.

Amendment A, which was approved by voters in the November 2020 election, would have legalized all forms of cannabis in addition to legalizing the growing, sale and licensing of cannabis in the state. The measure was approved with a margin of 8% and was to go into effect on July 1 this year.

Noem, who opposed the ballot initiative, ordered that the legal fees for the role Miller played in challenging the measure be paid for by the state.

Many expect that the decision will be appealed to the South Dakota Supreme Court.

The Attorney General’s office chief of staff Tim Bormann stated that the office, which was charged constitutionally with defending any ballot initiatives that were approved by voters in court, was currently reviewing the judge’s decision but declined to give any further commentary, adding that the office was treating this as an ongoing case.

The group that had placed the initiative on the voters’ ballot, Representing South Dakotans for Better Marijuana Laws, also gave its opinion on the judge’s decision. Brendan Johnson, who represents the group, stated that it disagreed with the judge’s ruling and would be appealing to the state’s Supreme Court.

Noem applauded the court’s ruling, stating that she expected an appeal on the judge’s ruling to have similar results. In a statement sent to a news outlet, she noted that the decision made by the judge protected and safeguarded the South Dakota state constitution, adding that she was confident that the state’s Supreme Court would came to a similar conclusion.

While South Dakota is still working to legalize cannabis, plenty of companies are thriving in jurisdictions with legal marijuana markets. For instance, Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) based in Canada has a vertical engaged in white labelling because its reputation commands customer interest, especially for edibles and oils.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How Is Marijuana Legalization Impacting Real Estate Prices?

The cannabis industry has come a long way from the days when states that didn’t criminalize the controversial drug were the exception rather than the norm. Now, 36 states have legalized medical use, 15 allow recreational use, and several more are considering cannabis legalization for the future. The road to legalization wasn’t easy, however, with most opponents arguing legalization would increase crime rates as well as cannabis and subsequent drug use among children.

Years later, we can see that most of those fears were unfounded. However, although marijuana legalization policies haven’t increased criminal activity or youth drug use, they have had quite an interesting effect on real estate, a report from the National Association of Realtors (“NAR”) says. In states where medical and recreational marijuana has been legal for more than three years, there has been an increased demand for commercial properties, the report found.

More than 40% of the states saw an uptick in demand for warehouses, 27% saw an increase in demand for storefronts, and 21% saw an increase in demand for land. For the states that had allowed recreational and medical marijuana the longest, 32% saw commercial leases add addendums addressing growing cannabis while 30% saw addendums concerning cannabis sales.

The NAR report indicates more mixed results on the residential front; states that had legal cannabis markets the longest experienced a 27% drop in residential property values close to cannabis dispensaries while 12% of the states saw an increase in prices. The decreasing property values caused landlords to add addendums to lease agreements, with 58% to 67% of residential property managers in areas with legal recreational cannabis seeing lease addendums that restrict smoking on their premises.

In Colorado and Washington, two states that have relatively successful cannabis industries, an SSRN study indicates that some neighborhoods in both states saw a 7% increase in prices due to newly opened marijuana dispensaries. According to the research, the impact of cannabis legalization on more expensive homes was different from its impact on less-expensive homes, although homes in all price levels saw an increase in value.

As more states legalize cannabis, especially recreational use, real estate markets in these states may see an uptick in homebuyers, including cannabis consumers as well as job seekers. And with more dispensaries opening to cater to the increasing demand, they will need more labor, leading to more demand for homes as more individuals are employed and settle in. Such markets will inevitably be looking at increased property rates coupled with higher rents.

Away from the impact of marijuana on real estate, interesting things are happening as the industry matures. A case in point is RYAH Group Inc., a company that focuses on developing IoT devices that can measure out, remotely, the appropriate quantity of cannabis-based medicines.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) Execs Appear on Leading Cannabis Investing Podcast

HempFusion Wellness (TSX: CBD.U) (OTC: CBDHF) (FWB: 8OO) co-founder and CEO Dr. Jason Mitchell and chief corporate officer Danny Brody were featured on a recent segment of the Cannabis Investing Podcast. The program provides actionable investment insight, context with which to understand the burgeoning cannabis industry, and interviews with C-level executives, scientists, law and sector experts. During their segment, Mitchell and Brody discussed highlights in the cannabis industry, including the recent multibillion deal between GW Pharma and Jazz Pharmaceuticals, as well as radical transparency, the industry’s methodical growth and how companies can become more efficient during COVID-19. They also discussed what makes HempFusion distinctive among other companies operating in the market and prospects of the company going public. From the beginning, HempFusion was committed to compliance, which was a different approach than others operating in the space. That commitment has served the company as the industry has grown and become more regulated; HempFusion is now ahead of the game because it is already compliant. The two also discussed the company’s future strategic plan. Mitchell noted that HempFusion is a completely science-backed company with patented products and proprietary delivery methods, very similar to GW Pharma. “The big fish are now circling,” said HempFusion Wellness co-founder and CEO Dr. Jason Mitchell during the show.

To listen to the podcast, visit https://cnw.fm/Pt08O

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to HempFusion are available in the company’s newsroom at https://cnw.fm/HempFusion

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — New Congressional Bill Could Allow CBD, Hemp to Be Sold as Dietary Supplements

The 2018 Farm Bill legalized the cultivation and sale of industrial hemp and hemp extracts, including cannabidiol (“CBD”), spawning what would soon be one of the most popular health and wellness ingredients in a long time. With both hemp and CBD boasting a wide array of benefits, a market products containing the two ingredients sprang up. Although the sector soon had thousands of sellers across the supply chain with CBD products attracting incredible demand, the U.S. Food and Drug Administration (“FDA”) was expressly against marketing and selling CBD products as dietary supplements.

However, thanks to a bill reintroduced into Congress by a bipartisan group of lawmakers, that may soon be a thing of the past. The bill, which was first filed by Representatives Kurt Schrader and Morgan Griffith last year, would allow hemp, hemp-derived CBD, and “any other ingredient derived from hemp” to be used as a dietary supplement under the Federal Food, Drug, and Cosmetic Act. This version of the bill, called the Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act, has 17 other cosponsors alongside the two congressmen.

For quite a while, the FDA has been under pressure to rein in the quickly growing CBD industry, called the “Wild West” by some. However, the agency has maintained that it may take a while to fully regulate CBD, offering enforcement discretion guidance in the meantime while it works on crafting formal rules for CBD. In 2019, a bipartisan coalition of 26 House members sent the FDA a letter saying that the agency’s current regulatory posture has led to significant “regulatory and legal uncertainty.”

The FDA opened a public comment period from April to July of 2019 asking the public to submit information about CBD; the agency reopened the comment period in March 2020. According to the agency, the comment period would allow stakeholders to provide new information in real time to the FDA that would help it “address uncertainties and data gaps” as it crafted CBD regulation.

The U.S. Hemp Roundtable has applauded the move, saying Schrader and Griffith have shown true leadership concerning CBD. Jonathan Miller, general counsel for the Roundtable, anticipates support for the CBD legislation will continue to build as it goes through Congress. The new bipartisan CBD marketing bill increases the number of bills addressing cannabis issues. The second is a bill to move cannabis’ place in the Controlled Substances Act from Schedule I to Schedule III; a third bill prevents the U.S. Department of Veterans from keeping veterans from accessing their benefits because of state-legal medical marijuana use.

In states with legal cannabis markets, innovation in the sector is booming. A clear example is the way in which CannAssist International Corp. (OTCQB: CNSC) is merging the worlds of biotechnology, the wellness industry and the pharmaceuticals industry to create cannabis products that offer consistent results and superior performance in many aspects, including better bioavailability.

NOTE TO INVESTORS: The latest news and updates relating to CannAssist International Corp. (OTCQB: CNSC) are available in the company’s newsroom at https://cnw.fm/CNSC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.